Viatris
VTRS
#1394
Rank
โ‚ฌ13.42 B
Marketcap
11,66ย โ‚ฌ
Share price
-1.39%
Change (1 day)
72.58%
Change (1 year)

Revenue for Viatris (VTRS)

Revenue in 2025 (TTM): โ‚ฌ12.40 Billion

According to Viatris's latest financial reports the company's current revenue (TTM ) is โ‚ฌ12.40 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ14.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Viatris from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ12.17 B-14.06%
2024 โ‚ฌ14.16 B1.5%
2023 โ‚ฌ13.95 B-7.95%
2022 โ‚ฌ15.16 B-4.01%
2021 โ‚ฌ15.79 B62.61%
2020 โ‚ฌ9.71 B-5.4%
2019 โ‚ฌ10.26 B2.72%
2018 โ‚ฌ9.99 B0.71%
2017 โ‚ฌ9.92 B-5.76%
2016 โ‚ฌ10.53 B22.11%
2015 โ‚ฌ8.62 B35.87%
2014 โ‚ฌ6.34 B26.87%
2013 โ‚ฌ5.00 B-2.33%
2012 โ‚ฌ5.12 B8.52%
2011 โ‚ฌ4.72 B15.19%
2010 โ‚ฌ4.09 B15.28%
2009 โ‚ฌ3.55 B-3.27%
2008 โ‚ฌ3.67 B
2006 โ‚ฌ1.15 B9.57%
2005 โ‚ฌ1.05 B12.6%
2004 โ‚ฌ0.93 B-15.48%
2003 โ‚ฌ1.10 B-3.33%
2002 โ‚ฌ1.14 B-5.41%
2001 โ‚ฌ1.21 B40.46%
2000 โ‚ฌ0.86 B13.31%
1999 โ‚ฌ0.76 B35.57%
1998 โ‚ฌ0.56 B30.31%
1997 โ‚ฌ0.43 B22.87%
1996 โ‚ฌ0.35 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚ฌ0.55 B-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA